KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,116 | +114.6% | 18,426 | +175.2% | 0.15% | +131.7% |
| Q2 2023 | $1,452 | -52.2% | 6,696 | -60.0% | 0.06% | -55.9% |
| Q1 2023 | $3,038 | +74.6% | 16,726 | +88.9% | 0.14% | +49.0% |
| Q4 2022 | $1,740 | -99.9% | 8,855 | +11.3% | 0.10% | -11.1% |
| Q3 2022 | $1,789,000 | +560.1% | 7,955 | +271.6% | 0.11% | +440.0% |
| Q2 2022 | $271,000 | 0.0% | 2,141 | 0.0% | 0.02% | +11.1% |
| Q1 2022 | $271,000 | – | 2,141 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |